This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations in Cancer Treatment by Inventor Archie Ngai-Chiu Tse
Introduction
Archie Ngai-Chiu Tse is a notable inventor based in Long Island City, NY, recognized for his significant contributions to the field of cancer treatment. With a total of 2 patents to his name, Tse's work focuses on innovative therapeutic combinations that target critical pathways in cancer biology.
Latest Patents
One of Archie Tse's latest patents involves the use of combinations of PD-1 antagonists and benzo[b]thiophene STING agonists for cancer treatment. This patent discloses therapeutic combinations that include at least one antagonist of the Programmed Death 1 receptor (PD-1) in conjunction with a benzo[b]thiophene compound that activates the Stimulator of Interferon Genes (STING) pathway. The use of these combinations is aimed at effectively treating various types of cancers.
Additionally, Tse has patented therapies that comprise administering at least one benzo[b]thiophene compound to activate the STING pathway. This patent highlights therapies in the treatment of cell-proliferation disorders, specifically cancers, showcasing the potential of these compounds in advancing cancer therapies.
Career Highlights
Archie Ngai-Chiu Tse is affiliated with Merck Sharp & Dohme Corporation, a leading global health company. His position at Merck has provided him with a platform to develop and advance groundbreaking therapeutic strategies that tackle cancer at its core.
Collaborations
Throughout his career, Tse has collaborated with talented individuals including Saso Cemerski and Jared N Cumming. These partnerships have undoubtedly enriched his research endeavors, contributing to the development of innovative cancer treatments.
Conclusion
Archie Ngai-Chiu Tse’s work encapsulates the essence of innovation in the biomedical field, particularly in cancer treatment. His research and patents signify a step forward in developing effective therapies against challenging diseases, bearing the potential to transform the lives of many patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile